FI20115670A0 - Kardiovaskulaarinen in vitro-malli - Google Patents
Kardiovaskulaarinen in vitro-malliInfo
- Publication number
- FI20115670A0 FI20115670A0 FI20115670A FI20115670A FI20115670A0 FI 20115670 A0 FI20115670 A0 FI 20115670A0 FI 20115670 A FI20115670 A FI 20115670A FI 20115670 A FI20115670 A FI 20115670A FI 20115670 A0 FI20115670 A0 FI 20115670A0
- Authority
- FI
- Finland
- Prior art keywords
- cardiovascular model
- relates
- model
- platform
- vitro
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1352—Mesenchymal stem cells
- C12N2502/1382—Adipose-derived stem cells [ADSC], adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/28—Vascular endothelial cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20115670A FI20115670A0 (fi) | 2011-06-23 | 2011-06-23 | Kardiovaskulaarinen in vitro-malli |
JP2014516404A JP2014519837A (ja) | 2011-06-23 | 2012-06-14 | インビトロの心臓血管モデル |
EP12803040.0A EP2723853B1 (en) | 2011-06-23 | 2012-06-14 | In vitro cardiovascular model |
PCT/FI2012/050611 WO2012175797A1 (en) | 2011-06-23 | 2012-06-14 | In vitro cardiovascular model |
CA2839052A CA2839052A1 (en) | 2011-06-23 | 2012-06-14 | In vitro cardiovascular model |
CN201280030909.0A CN103814124A (zh) | 2011-06-23 | 2012-06-14 | 体外心血管模型 |
BR112013033246A BR112013033246A2 (pt) | 2011-06-23 | 2012-06-14 | modelo cardiovascular in vitro |
DK12803040.0T DK2723853T3 (en) | 2011-06-23 | 2012-06-14 | In vitro cardiovascular model |
KR1020147000113A KR20140048190A (ko) | 2011-06-23 | 2012-06-14 | 시험관내 심혈관 모델 |
US14/128,766 US20140206029A1 (en) | 2011-06-23 | 2012-06-14 | In vitro cardiovascular model |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20115670A FI20115670A0 (fi) | 2011-06-23 | 2011-06-23 | Kardiovaskulaarinen in vitro-malli |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20115670A0 true FI20115670A0 (fi) | 2011-06-23 |
Family
ID=44206878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20115670A FI20115670A0 (fi) | 2011-06-23 | 2011-06-23 | Kardiovaskulaarinen in vitro-malli |
Country Status (10)
Country | Link |
---|---|
US (1) | US20140206029A1 (fi) |
EP (1) | EP2723853B1 (fi) |
JP (1) | JP2014519837A (fi) |
KR (1) | KR20140048190A (fi) |
CN (1) | CN103814124A (fi) |
BR (1) | BR112013033246A2 (fi) |
CA (1) | CA2839052A1 (fi) |
DK (1) | DK2723853T3 (fi) |
FI (1) | FI20115670A0 (fi) |
WO (1) | WO2012175797A1 (fi) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940997A (zh) * | 2014-03-27 | 2015-09-30 | 复旦大学 | 一种组织工程化人类心肌组织 |
CN105838670A (zh) * | 2015-01-13 | 2016-08-10 | 上海交通大学医学院附属第九人民医院 | 一种细胞混合物及其制备方法和用途 |
US20190017029A1 (en) * | 2016-02-25 | 2019-01-17 | The J. David Gladstone Institutes, a testament trust established under the Will of J. David | Generation of Expandable Cardiovascular Progenitor Cells |
CN105911096B (zh) * | 2016-03-29 | 2018-07-10 | 南京艾尔普再生医学科技有限公司 | 一种可以体外进行药物药理毒理筛查的人工心脏系统 |
IT201800007946A1 (it) * | 2018-08-07 | 2020-02-07 | 1Lab Sa | Modello per simulare in-vitro il comportamento di vasi disfunzionali |
EP3950711A4 (en) * | 2019-04-01 | 2022-12-21 | Toppan Inc. | CELL CONSTRUCT AND METHODS OF PRODUCTION |
CN111793609B (zh) * | 2020-09-08 | 2020-12-29 | 北京达熙生物科技有限公司 | 一种促进脂肪干细胞增殖和分化的方法 |
JPWO2022113540A1 (fi) * | 2020-11-26 | 2022-06-02 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002078439A2 (en) * | 2001-03-30 | 2002-10-10 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Prevascularized constructs for implantation to provide blood perfusion |
US7052829B2 (en) * | 2001-03-30 | 2006-05-30 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Prevascularized constructs for implantation to provide blood perfusion |
AU2003220424A1 (en) * | 2002-03-19 | 2003-10-08 | Advanced Research And Technology Transfer | Adipose stromal stem cells for tissue and vascular modification |
FR2859381B1 (fr) * | 2003-09-05 | 2008-07-25 | Centre Nat Rech Scient | Utilisaton de cellules issues du tissu adipeux pour induire la formation d'un reseau vasculaire fonctionnel |
RU2334793C1 (ru) | 2007-02-20 | 2008-09-27 | Федеральное Государственное Учреждение "Российский кардиологический научно-производственный комплекс Федерального агентства по здравоохранению и социальному развитию" | Способ получения культуры клеток с индуцированным ангиогенным фенотипом, предназначенной для тканевой инженерии в зоне ишемии |
ES2325715B1 (es) | 2007-08-03 | 2010-06-17 | Genetrix, S.L. | Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca. |
US20090169521A1 (en) | 2007-12-31 | 2009-07-02 | Technion Research & Development Foundation Ltd. | Vascularized cardiac tissue and methods of producing and using same |
WO2010017378A2 (en) * | 2008-08-08 | 2010-02-11 | Indiana University Research And Technology Corporation | Methods and compositions for vasculogenic potential determination |
US8727965B2 (en) * | 2010-03-05 | 2014-05-20 | Tissue Genesis, Inc. | Methods and compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells |
-
2011
- 2011-06-23 FI FI20115670A patent/FI20115670A0/fi not_active Application Discontinuation
-
2012
- 2012-06-14 JP JP2014516404A patent/JP2014519837A/ja active Pending
- 2012-06-14 DK DK12803040.0T patent/DK2723853T3/en active
- 2012-06-14 CA CA2839052A patent/CA2839052A1/en not_active Abandoned
- 2012-06-14 BR BR112013033246A patent/BR112013033246A2/pt not_active IP Right Cessation
- 2012-06-14 CN CN201280030909.0A patent/CN103814124A/zh active Pending
- 2012-06-14 US US14/128,766 patent/US20140206029A1/en not_active Abandoned
- 2012-06-14 KR KR1020147000113A patent/KR20140048190A/ko not_active Application Discontinuation
- 2012-06-14 WO PCT/FI2012/050611 patent/WO2012175797A1/en active Application Filing
- 2012-06-14 EP EP12803040.0A patent/EP2723853B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
JP2014519837A (ja) | 2014-08-21 |
DK2723853T3 (en) | 2018-04-16 |
CA2839052A1 (en) | 2012-12-27 |
EP2723853B1 (en) | 2017-12-27 |
BR112013033246A2 (pt) | 2017-03-01 |
US20140206029A1 (en) | 2014-07-24 |
WO2012175797A1 (en) | 2012-12-27 |
EP2723853A4 (en) | 2015-07-22 |
CN103814124A (zh) | 2014-05-21 |
EP2723853A1 (en) | 2014-04-30 |
KR20140048190A (ko) | 2014-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI20115670A0 (fi) | Kardiovaskulaarinen in vitro-malli | |
BR112014005355A2 (pt) | células t de memória central anti-terceiro, métodos de produção e uso das mesmas em transplante e tratamento de doença | |
GT201400162A (es) | Composición y método para el diagnóstico y el tratamiento de las enfermedades asociadas a la degeneración de las neuritas | |
AR079889A1 (es) | Antagonistas de wnt y metodos de tratamiento y deteccion | |
WO2012149299A3 (en) | Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor | |
EP2826855A4 (en) | METHOD FOR PRODUCING MIXTURE OF CARDIAC AND VASCULAR CELLS FROM ARTIFICIAL PLURIPOTENT STEM CELLS | |
BR112013024574A2 (pt) | polipeptídeo, uso, método de tratamento de indivíduos portadores de doenças e método de tratamento de indivíduos que possuem doenças com um polipeptídeo | |
BR112014005752A2 (pt) | plataforma para tecidos e órgãos implantáveis produzidos por engenharia tecidual e métodos para sua produção | |
BR112013010015A2 (pt) | aparelho e método para detecção não invasiva de doenças que afetam as propriedades estruturais em tecidos biológicos | |
EE05601B1 (et) | Seade ja meetod pehme bioloogilise koe mehaanilise pingeseisundi, elastsuse, dnaamilise jikuse, roomavuse ja mehaanilise pinge relaksatsiooniaega iseloomustavate parameetrite samaaegseks m??tmiseks reaalajas ning arvutiprogrammi produkt | |
ECSP14002542A (es) | Nuevos 2hindazoles como antagonistas del receptor ep2 | |
EA201591742A1 (ru) | Способ улучшения диагностики заболеваний с использованием измеряемых аналитов | |
BR112014007007A2 (pt) | método de diferenciação precoce, método de diagnóstico de fibrilação, uso de troponina cardíaca, dispositivo de diferenciação e dispositivo de diagnóstico | |
WO2014140362A3 (en) | Lymphocyte biomarkers for determining the clinical response to therapy with mesenschymal stromal cells(msc) | |
WO2013184193A3 (en) | Cancer stem cells and methods of using the same | |
EP2894219A4 (en) | ARTIFICIAL SKIN FABRIC, ARTIFICIAL SKIN MODEL AND METHOD OF MANUFACTURING THE SAME | |
EP2772760A4 (en) | METHOD FOR MEASURING A BIOLOGICAL ACTIVE BIOLOGICAL ACTIVE SUBSTANCE AND MICROPARTICLE AND EXTRACT FOR USE IN THIS METHOD | |
EP2610337A4 (en) | MASS TEST OF BLOOD CELL BLOOD CELLS USING CELL COAGULATION, ADULT BLOOD STEM CELLS USING THE SAME, METHOD OF EXPANDING PROGENITOR CELLS AND STEM CELLS PRODUCED USING THE METHOD | |
BR112014010166A8 (pt) | uso de uma composição para a fabricação de um produto para melhorar a pontuação na bateria de testes neuropsicológicos, método para avaliar a cognição de um indivíduo e uso de uma composição para a fabricação de um produto para tratar um indivíduo em necessidade da mesma | |
EP2566879A4 (en) | METHOD FOR FUNCTIONALIZATION OF HUMAN RED GLOBES USING ANTIBODIES | |
FR2962443B1 (fr) | Modele de tissu adipeux et procede de preparation | |
EA201301080A1 (ru) | Применение солей 3-карбокси-n-этил-n,n-диметилпропан-1-аммония при лечении сердечно-сосудистого заболевания | |
EP2903507A4 (en) | ELECTRO-MECHANICAL MEASUREMENT OF THE ACTIVITY OF STAPEDIUS MUSCLES / SIDS | |
RU2012118140A (ru) | Способ индивидуального назначения системной пульс-терапии глюкокортикостероидами пациентам с эндокринной офтальмопатией | |
UA74784U (ru) | Способ оценки состояния миокарда левого желудочка, преимущественно, после стентирования коронарных артерий |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |